Citadel Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,202
Closed -$6.61K 6955
2022
Q4
$6.61K Buy
+15,202
New +$6.61K ﹤0.01% 5743
2022
Q3
Hold
0
7074
2022
Q2
Sell
-208,065
Closed -$139K 7317
2022
Q1
$139K Buy
208,065
+73,055
+54% +$48.8K ﹤0.01% 5496
2021
Q4
$174K Buy
135,010
+76,470
+131% +$98.6K ﹤0.01% 5578
2021
Q3
$127K Buy
58,540
+13,541
+30% +$29.4K ﹤0.01% 5704
2021
Q2
$123K Buy
44,999
+13,307
+42% +$36.4K ﹤0.01% 5865
2021
Q1
$83K Sell
31,692
-36,739
-54% -$96.2K ﹤0.01% 5935
2020
Q4
$190K Buy
68,431
+5,987
+10% +$16.6K ﹤0.01% 4525
2020
Q3
$288K Sell
62,444
-704,972
-92% -$3.25M ﹤0.01% 3865
2020
Q2
$2.16M Sell
767,416
-87,855
-10% -$248K ﹤0.01% 2178
2020
Q1
$2.09M Buy
855,271
+712,470
+499% +$1.74M ﹤0.01% 2181
2019
Q4
$731K Sell
142,801
-488,286
-77% -$2.5M ﹤0.01% 3274
2019
Q3
$4.08M Sell
631,087
-145
-0% -$937 ﹤0.01% 1815
2019
Q2
$3.93M Buy
631,232
+414,982
+192% +$2.59M ﹤0.01% 1847
2019
Q1
$2.3M Buy
216,250
+212,178
+5,211% +$2.26M ﹤0.01% 2200
2018
Q4
$32K Buy
4,072
+1,596
+64% +$12.5K ﹤0.01% 4170
2018
Q3
$48K Sell
2,476
-15,180
-86% -$294K ﹤0.01% 4015
2018
Q2
$319K Sell
17,656
-98
-0.6% -$1.77K ﹤0.01% 3409
2018
Q1
$189K Sell
17,754
-53,796
-75% -$573K ﹤0.01% 3504
2017
Q4
$3.02M Sell
71,550
-89,176
-55% -$3.76M ﹤0.01% 1618
2017
Q3
$8.85M Buy
160,726
+123,042
+327% +$6.77M 0.01% 982
2017
Q2
$6.99M Sell
37,684
-39,943
-51% -$7.41M 0.01% 1026
2017
Q1
$9.28M Buy
77,627
+43,543
+128% +$5.2M 0.01% 928
2016
Q4
$3.39M Buy
+34,084
New +$3.39M ﹤0.01% 1233
2016
Q3
Sell
-71,585
Closed -$7.35M 4224
2016
Q2
$7.35M Buy
71,585
+64,052
+850% +$6.58M 0.01% 851
2016
Q1
$692K Buy
7,533
+6,597
+705% +$606K ﹤0.01% 2028
2015
Q4
$135K Sell
936
-3,274
-78% -$472K ﹤0.01% 3132
2015
Q3
$435K Sell
4,210
-24
-0.6% -$2.48K ﹤0.01% 2698
2015
Q2
$691K Buy
+4,234
New +$691K ﹤0.01% 2355